Show us your assays and other things, page-4

TYX can't afford the Challenger plant. Byrnecut won't be selling it cheaply as they effectively own it and it owes them plenty.

It will be a mid sized company that takes it over imo. TYX will probably either sell their share of the Jumbuck project to whoever becomes their new partner or renegotiate the jv structure so that they don't have to contribute any more cash to it, like they did with the Wilcherry project. I'm in favour of a full sell out.

They have no money and very little opportunity to raise any. Their investments in OGX and KAI have turned to crap. Eureka becomes their only viable opportunity of cashflow, other than a very dilutive cap raising.

Even with the money from the Wilcherry and camp sale, TYX will still require a cash injection prior to any money from toll treating hitting the bank. Jumbuck becomes the obvious choice to offload and remove the company from SA completely. Buying more assets such as Challenger without any means to pay for them, or to spend the necessay cash to prove up reserves (not just resources), would be irresponsible.